(Q53064404)

11 May 2018

title

Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone. (English)

1 reference

11 May 2018

author

Daniela Merlotti

1

1 reference

11 May 2018

Fernando Gianfrancesco

5

1 reference

11 May 2018

author name string

Domenico Rendina

2

1 reference

11 May 2018

Luigi Gennari

3

1 reference

11 May 2018

Giuseppe Mossetti

4

1 reference

11 May 2018

Giuseppe Martini

6

1 reference

11 May 2018

Gianpaolo De Filippo

7

1 reference

11 May 2018

Annalisa Avanzati

8

1 reference

11 May 2018

Beatrice Franci

9

1 reference

11 May 2018

Maria Stella Campagna

10

1 reference

11 May 2018

Pasquale Strazzullo

11

1 reference

11 May 2018

Ranuccio Nuti

12

1 reference

11 May 2018

publication date

1 March 2011

1 reference

11 May 2018

Journal of Bone and Mineral Research

published in

1 reference

11 May 2018

volume

26

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

page(s)

512-518

1 reference

11 May 2018

Update on the epidemiology of Paget's disease of bone.

cites work

1 reference

Incidence and natural history of Paget's disease of bone in England and Wales.

21 January 2018

1 reference

Paget's disease of bone and quality of life.

21 January 2018

1 reference

Guidelines on the management of Paget's disease of bone

21 January 2018

1 reference

The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.

21 January 2018

1 reference

Acquired resistance to bisphosphonates in Paget's disease of bone.

21 January 2018

1 reference

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite

21 January 2018

1 reference

Bisphosphonate actions: physical chemistry revisited

21 January 2018

1 reference

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

21 January 2018

1 reference

Treatment of Paget's disease of bone: a survey of clinical practice in Australia

21 January 2018

1 reference

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group

21 January 2018

1 reference

Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates

21 January 2018

1 reference

Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another.

21 January 2018

1 reference

Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies.

21 January 2018

1 reference

Intramuscular neridronate in postmenopausal women with low bone mineral density.

21 January 2018

1 reference

Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion

21 January 2018

1 reference

Transcriptional profiling of gamma delta T cells identifies a role for vitamin D in the immunoregulation of the V gamma 9V delta 2 response to phosphate-containing ligands

21 January 2018

1 reference

The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis

21 January 2018

1 reference

Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients

21 January 2018

1 reference

Vitamin D status and response to treatment in post-menopausal osteoporosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.237

1 reference

11 May 2018

1 reference

11 May 2018